Literature DB >> 9843183

Adhesion of leukocytes to growing arterial thrombi.

I A Hagberg1, H E Roald, T Lyberg.   

Abstract

Since the role of leukocytes found present in thrombi and haemostatic plugs is not clearly understood. we have investigated the interaction between leukocytes and growing thrombi in a human ex vivo model of arterial thrombogenesis. At a wall shear rate characteristic of moderately stenosed arteries (2600 s(-1)), granulocytes selectively accumulated at the luminal surface of platelet thrombi. The leukocyte adhesion seemed independent of fibrin formation and was clearly correlated to thrombus growth and platelet activation. In contrast, flow cytometry revealed that the expression of adhesion molecules (CD11a, CD11b, CD11, CD3, CD14, CD62L, HLA-DR and binding of fibrinogen) on the surface of circulating leukocytes passing the thrombi was, on short term conditions (15 min), independent of thrombus growth. The adhered granulocytes probably play a pivotal role in limiting the size of the evolving thrombi, as suggested by our electron micrographs of the arterial thrombi showing lysed and phagocytosed platelets. Thus, granulocytes might play an active role in the acute/semiacute phase of local thromboregulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843183

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates.

Authors:  András Gruber; Ulla M Marzec; Leslie Bush; Enrico Di Cera; José A Fernández; Michelle A Berny; Erik I Tucker; Owen J T McCarty; John H Griffin; Stephen R Hanson
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

2.  Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution.

Authors:  Ziad Touat; Veronique Ollivier; Jianping Dai; Marie-Genevieve Huisse; Annie Bezeaud; Uriel Sebbag; Tony Palombi; Patrick Rossignol; Olivier Meilhac; Marie-Claude Guillin; Jean-Baptiste Michel
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  Leukocyte integrin Mac-1 (CD11b/CD18, αMβ2, CR3) acts as a functional receptor for platelet factor 4.

Authors:  Valeryi K Lishko; Valentin P Yakubenko; Tatiana P Ugarova; Nataly P Podolnikova
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

4.  Contribution of neutrophil elastase to the lysis of obliterative thrombi in the context of their platelet and fibrin content.

Authors:  Gyöngyi Rábai; Nóra Szilágyi; Péter Sótonyi; Ilona Kovalszky; László Szabó; Raymund Machovich; Krasimir Kolev
Journal:  Thromb Res       Date:  2010-08       Impact factor: 3.944

5.  The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi.

Authors:  Mehran Ghasemzadeh; Zane S Kaplan; Imala Alwis; Simone M Schoenwaelder; Katrina J Ashworth; Erik Westein; Ehteramolsadat Hosseini; Hatem H Salem; Robyn Slattery; Shaun R McColl; Michael J Hickey; Zaverio M Ruggeri; Yuping Yuan; Shaun P Jackson
Journal:  Blood       Date:  2013-04-02       Impact factor: 22.113

6.  Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus.

Authors:  Vincent Fontaine; Ziad Touat; El Mostafa Mtairag; Roger Vranckx; Liliane Louedec; Xavier Houard; Bernard Andreassian; Uriel Sebbag; Tonino Palombi; Marie-Paule Jacob; Olivier Meilhac; Jean-Baptiste Michel
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

7.  Direct observation of membrane tethers formed during neutrophil attachment to platelets or P-selectin under physiological flow.

Authors:  D W Schmidtke; S L Diamond
Journal:  J Cell Biol       Date:  2000-05-01       Impact factor: 10.539

8.  Neutrophils can promote clotting via FXI and impact clot structure via neutrophil extracellular traps in a distinctive manner in vitro.

Authors:  Y Shi; J S Gauer; S R Baker; H Philippou; S D Connell; R A S Ariëns
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.